The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
MultiHance
gadobenate dimeglumine · GADOBENATE DIMEGLUMINE 529 mg/mL · Injection, Solution · Intravenous · Bracco Diagnostics Inc
NDC 00270-5164-12 · 5 VIAL, SINGLE-DOSE in 1 BOX / 5 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicare Part B (ASP)
Payment limit per 1 ML
$1.791
HCPCS A9577 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis
- BIPSO GmbHGermanyanalysis · manufacture
- Bracco Imaging SpaItalyapi manufacture
- Labor LS SE & Co. KGGermanyanalysis
- Patheon Italia S.p.AItalyanalysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA021357
- TE code
- —
- Approval date
- Nov 23, 2004
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class III · TerminatedApr 16, 2012Bracco Diagnostics Inc — Short Fill: The product is being recalled due to a potential underfill of the affected vials.
Manufacturers of gadobenate dimeglumine (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | GADOBENATE DIMEGLUMINE 529 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "MultiHance — NDC 00270-5164-12," retrieved September 3, 2026, https://drugdashboards.com/drug/00270516412.
Free to cite with attribution — see how the data is put together.